Kenmotsu, H., Watanabe, Y., Itoh, S., Ichihara, E., Tanaka, H., Azuma, K., Arai, R., Kuyama, S., Akamatsu, H., Otsubo, K., Ajimizu, H., Seto, Y., Uchibori, K., Hayashi, H., Miyauchi, E., Ozawa, Y., Ishizuka, N., Nakagawa, Y., Katayama, R. (2026). Resistance mechanisms and efficacy of first-line alectinib and sequential treatments in advanced ALK + NSCLC: Real-world outcomes from a multicenter, observational study in Japan (ALCURE).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8604